Sleep-wake Disorder in Blind Individuals

0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

1 companies ranked by most advanced pipeline stage

VP
Vanda PharmaceuticalsWASHINGTON, DC
1 program
Data collection on blindness and sleep problemsN/A1 trial
Active Trials
NCT01195558Recruiting10,000Est. Apr 2030

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
Vanda PharmaceuticalsData collection on blindness and sleep problems

Clinical Trials (1)

Total enrollment: 10,000 patients across 1 trials

NCT01195558Vanda PharmaceuticalsData collection on blindness and sleep problems

Patient Registry of Blind Subjects With Sleep-related Problems

Start: Apr 2010Est. completion: Apr 203010,000 patients
N/ARecruiting

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 actively recruiting trials targeting 10,000 patients
1 companies competing in this space